Completed

Limit: 1 // Tickets Available: 1

Kenry (Pharmacology and Toxicology) 

The University of Arizona Cancer Center (UACC) can nominate one individual for the 2026 Pew-Stewart Scholars for Cancer Research program. For more information please contact: UACC-PreAward.

In line with The Stewart Trust’s mission to invest in innovative, cutting-edge cancer research that may accelerate and advance progress toward a cure for cancer, applications are invited from nominees conducting cancer research at NCI-designated cancer centers, or cancer-focused institutions. The Pew-Stewart Scholars Program for Cancer Research is distinct from the Pew Scholars Program, and it follows a different, but parallel set of guidelines and procedures for nominating an applicant whose research is related to cancer.

In early April 2025, a letter of invitation and application instructions will be sent to the leaders of the cancer research institutions selected to submit a nominee for the 2026 class. Centers are expected to complete a limited submission competition in order to identify and select one nominee. For guidance on this process, please contact Pew-Stewart@pewtrusts.org.

• Center administration should distribute this invitation and award eligibility details to all investigators via an email announcement or website posting.
• Interested applicants should submit pre-proposal material to an internal selection committee for consideration.
• To nominate a candidate, a member of the internal selection committee must complete an online survey from the Pew program office describing the selection process used by the institution and submit the name and contact information of the chosen applicant by May 14, 2025.
• Nominations of applicants to the program will not be considered after May 14, 2025.
• The Pew program office will email grant application portal login information and a detailed application guide directly to all nominated applicants by June 11, 2025. The online application website will open on June 11, 2025.
• For research administrators assisting an applicant, please send an email with your grant applicant cc’ed to Pew-Stewart@pewtrusts.org after June 11, 2025, to receive access to the portal. No requests will be accepted prior to this date.
• The application submission deadline is Aug. 27, 2025.
• Every application will be reviewed by the program's National Advisory Committee. The committee will make recommendations to the board of directors of The Pew Charitable Trusts in April 2026. Candidates will be notified in April if they have been recommended to the Stewart and Pew boards.
• A public announcement of the award will be made in June. Grant agreements will be issued to the grant hosting institution of each scholar in August of the award year.

No Applicants // Limit: 2 (1 Translational nominee, 1 All-Star Translational nominee) // Tickets Available: 2 

The University of Arizona Cancer Center (UACC) can nominate up to two proposals: one Translational nominee and one All-Star Translational nominee (if eligible) for the V Foundation Adult Translational Cancer Research Award 2025. 

For more information please contact: UACC-PreAward.

Purpose of Award:

The UACC is seeking nominations for the Translational Adult Cancer Research Grant which advances basic laboratory discoveries towards clinical use, ultimately improving human health and is restricted to adult cancer research.

This Translational grant is restricted to adult cancer research in the preclinical or translational space with a focus on bench-to-bedside strategies. Research on ANY adult cancer type can be funded. Applicants may propose cancer research that moves a novel strategy from the laboratory into a human clinical trial or uses specimens from a clinical trial to test hypotheses, develop biomarkers, or mechanisms. The research must apply in a direct way to human beings within 3 years from the end of the grant. If biomarker research is undertaken, a validation set or independent clinical trial is essential. A plan for biomarker validation, if applicable, must be included in any proposal. The endpoint of the project should be the planning or initiation of a new clinical trial or conducting an investigator-initiated trial with laboratory correlates that test hypotheses. Research areas not included in this scope are epidemiology, behavioral science, and health services research.

Limit: 1 per SIP

K. Ellingson (Public Health) for SIP25-005 Understanding the potential of early childcare and education (ECE) centers in promoting childhood vaccines and RSV prevention products

S. Carvajal (College of Public Health's Prevention Research Center) for SIP25-006 Overdose Prevention and Treatment Research Network (OPTRN)

Eligibility: 
Only one application per SIP per institution is allowed (e.g., multiple applications for the same SIP (listed in Section VIII) from the same institution are NOT permitted).

Purpose:
This Notice of Funding Opportunity (NOFO) invites applications from CDC Health Promotion and Disease Prevention Research Centers (PRCs), selected for funding under RFA-DP-24-004, to apply for supplemental funding to conduct Special Interest Research Projects (SIPs) to inform public health practice. PRCs will conduct high-quality applied health promotion and disease prevention research projects in real-world settings to identify, design, test, evaluate, disseminate, and translate interventions (i.e., programs, practices, policies, or strategies) to prevent and reduce risk for the leading causes of illness, disability, and death in the United States.

No Applicants // Limit: 2 // Tickets Available: 2

Number of Applications
The NIH will not accept duplicate or highly overlapping applications under review at the same time, per 2.3.7.4 Submission of Resubmission Application. This means that the NIH will not accept:

• A new (A0) application that is submitted before issuance of the summary statement from the review of an overlapping new (A0) or resubmission (A1) application.
• A resubmission (A1) application that is submitted before issuance of the summary statement from the review of the previous new (A0) application.
• An application that has substantial overlap with another application pending appeal of initial peer review (see 2.3.9.4 Similar, Essentially Identical, or Identical Applications).

Two applications per institution (with a Unique Entity Identifier ) and a unique NIH eRA Institutional Profile File (IPF) number) are allowed per review round. The same or a similar topic may be submitted for subsequent review rounds involving the same or a similar team, but must be presented as a New application, not a Resubmission.

Applications that are not considered to be within the NIGMS mission will not be reviewed. Eligibility and appropriateness to the NIGMS mission will be evaluated again after review and prior to funding. Applications outside the NIGMS mission will not be funded. Given that only two applications are permitted per institution per review round, it is important to contact NIGMS staff before committing to any particular team and its topic area.

Purpose: 
This Funding Opportunity Announcement (FOA) is designed to support highly integrated research teams of three to six Program Directors/Principal Investigators (PDs/PIs) to address ambitious and challenging research questions that are within the mission of NIGMS. Project goals should not be achievable with a collection of individual efforts or projects. Collaborative program teams are expected to accomplish goals that require considerable synergy and managed team interactions. Teams are encouraged to consider far-reaching objectives that will produce major advances in their fields.

This FOA is not intended for applications that are mainly focused on the creation, expansion, and/or maintenance of community resources, creation of new technologies, or infrastructure development.

Request Ticket // Limit: 4* (1 per grant type) // Tickets Available: 2

Legacy Researcher Grant // Limit 1 // Tickets Available: 1

Translational Research Grant // Limit: 1 // Tickets Available: 0
K. Huntoon (Neurosurgery) 

Emerging Investigator Fellowship Grant // Limit: 1 // Tickets Available: 0
S. Ganesh (Biomedical Engineering) 

Donor Designated Grant Program // Limit: 1 // Tickets Available: 1

Eligibility
Provide the name of the Institution, Principal Investigator and their title. An institution may only submit one LOI per award type. Multiple LOIs should not be submitted by the same researcher. 

Grant Categories 
The Pediatric Cancer Research Foundation awards four types of research grants: 

1. Legacy Researcher Grant (up to $100,000 per year, up to 2 years for translational research and up to $150,000 per year, for three years, for basic science research) 
   This grant is given to a long-standing PCRF-funded researcher for at least five years, who has demonstrated consistent progress and outcomes in pediatric cancer research. This funding category aims to support and sustain ongoing initiatives, ensuring that momentum is maintained on critical projects with potential for cures.  
2. Translational Research Grants (up to $100,000 per year, up to 2 years)  
   This grant is given to single or multi-institutional programs that involve open, cancer clinical trials or consortia, and implement new approaches to therapy. These grants support “bench to bedside” research, whose endpoint is often the planning or initiation of a clinical trial. 
3. Emerging Investigator Fellowship Grants (up to $75,000 for one year) 
   These grants are designed to support Post-Doctoral Fellowships and Clinical Investigator training for emerging pediatric cancer researchers to pursue exciting research ideas. Applicants must have completed two years of their fellowship or not more than two years as a junior faculty instructor or assistant professor at the start of the award period. These grants encourage and cultivate the best and brightest researchers of the future. 
4. Donor Designated Grant Programs 
   These grants fund projects in communities or regions local to the specific donor or fundraising activity. Outside contributing organizations, fundraisers and donors work with the Foundation to identify a specific project and/or specific doctor, focus on a specific disease type, facility or awareness program. Grants can be for any specific amount as designated by the donor or contributing organization. PCRF will not accept grant application without an approved Letter of Intent (LOI). Please refer to the guidelines contained in this document for the specific guidelines. 
    

Major divisions (e.g., College of Arts and Sciences, Medical School) of an institution may nominate only one applicant each year.

College of Engineering - E. Lee (Electrical and Computer Engineering)

The William T. Grant Scholars Program supports career development for promising early-career researchers. The program funds five-year research and mentoring plans that significantly expand researchers’ expertise in new disciplines, methods, and content areas.

Nomination Statement Requirements
This statement from the Dean or chairperson of the nominating division should describe why the applicant was selected; an assessment of the applicant’s plan; the applicant’s current and expected future roles in the division; the supporting resources available; the applicant’s current source and amount of salary; and the appointment, promotion, and institutional support plans for the applicant, including a guarantee that 50 percent of the applicant’s paid time will be devoted to research. (Successful examples of nominating statements can be found on the Foundation’s website.)

Focus Areas:

• Reducing Inequality
  • In this focus area, we fund research studies that aim to build, test, or increase understanding of programs, policies, or practices to reduce inequality in the academic, social, behavioral, or economic outcomes of young people ages 5–25 in the United States, along dimensions of race, ethnicity, economic standing, sexual or gender minority status, language minority status, or immigrant origins.
• Improving the Use of Research Evidence
  • In this focus area, we support research on strategies focused on improving the use of research evidence in ways that benefit young people ages 5-25 in the United States. We want to know what it takes to get research used by decision-makers and what happens when research is used. We welcome letters of inquiry for studies that pursue one of these broad aims.
    
    While an extensive body of knowledge provides a rich understanding of specific conditions that foster the use of research evidence, we lack robust, validated strategies for cultivating them. What is required to create structural and social conditions that support research use? What infrastructure is needed, and what will it look like? What supports and incentives foster research use? And, ultimately, how do youth outcomes fare when research evidence is used? This is where new research can make a difference.

Eligible Applicants 

• Applicants must be nominated by their institutions. Major divisions of an institution (e.g., College of Arts and Sciences, Medical School) may nominate only one applicant each year.  In addition to the eligibility criteria below, deans and directors of those divisions should refer to the Review Criteria to aid them in choosing their nominees. Applicants of any discipline are eligible. 

• Applicants must have received their doctorate within seven years of submitting their application. We calculate this by adding seven to the year the doctorate was conferred. In medicine, the seven-year maximum is dated from the completion of the first residency. The month in which the degree was conferred or residency completed  does not matter for this calculation. 

• Applicants must be employed in career-ladder positions. For many applicants, this means holding a tenure-track position in a university. Applicants in other types of organizations should be in positions in which there is a pathway to advancement in a research career at the organization and the organization is fiscally responsible for the applicant’s position. The award may not be used as a post-doctoral fellowship. 

• Applicants outside the United States are eligible. As with U.S. applicants, they must pursue research that has compelling policy or practice implications for youth in the United States. 

• We strive to support a diverse group of researchers in terms of race, ethnicity, gender, and seniority, and we encourage research projects led by Black or African American, Indigenous, Latinx, and/or Asian or Pacific Islander American  researchers.

Limit: 1 // Tickets Available: 0
Q. Hao (Aerospace & Mechanical Engineering) 

Eligibility 
One (1) per organization as lead institution.

The scientific focus of the MIP program is subject to change from competition to competition. Information about the existing MIPs, from two previous competitions in 2015 and 2019, can be found at mip.org. The third MIP competition, in 2025, will accept proposals on alloys, amorphous, and composite materials. Given that the second MIP competition included an emphasis on biomaterials and polymer research, proposals mainly on these topics will not be considered in the third MIP competition.

Limit: 1 // Tickets Available: 0 

E. Gumm (Psychiatry - COM-T)

Application Limits
You may not submit more than one application. If you submit more than one
application, we will only accept the last on-time submission.|

If an entity applies as part of a consortium, the entity is not eligible to submit a
separate, stand-alone application.

Purpose
The purpose of the Addiction Medicine Fellowship (AMF) program is to expand the
number of fellows at accredited AMF and Addiction Psychiatry Fellowship (APF)
programs trained as addiction medicine specialists who practice in medically
underserved, community-based settings that integrate primary care with mental health
disorder and substance use disorder (SUD) prevention and treatment services. The
fellowship must include training in prevention and treatment services in medically
underserved, community-based settings, including in rural areas, that do not have
access or have limited access to SUD treatment. The program includes training for both
addiction medicine and/or addiction psychiatry fellows. Its goal is to increase the
number of physicians who are board-certified specialists in addiction medicine or
addiction psychiatry who will serve in medically underserved community-based
settings, including in rural areas, once trained. The program supports training to:
 

• Increase the number of fellows trained to practice addiction medicine and
  addiction psychiatry in rural and other medically underserved community-based
  settings.
• Establish partnerships with clinical rotation sites in rural or other underserved
  areas, that focus on the integration of primary care with mental health and SUD
  prevention and treatment services.
• Increase fellows’ knowledge and ability to assist their patients with referrals to
  navigate the legal and social systems related to patients’ clinical or care needs.
• Increase awareness of the specialty and reduce provider stigma to increase the
  number of physicians interested in pursuing careers in addiction medicine and
  addiction psychiatry through the provision of clinical rotations that expose
  medical residents to practice in these specialties and through education and
  consultation.

Limit: 1 // Tickets Available: 0

M.M. Kaelberer (Physiology) 

The current grant level is $300,000; $75,000 per year for a four-year period. For the 2026 award, one nomination will be invited from each of the participating institutions listed at the bottom of this page.

Eligibility

• Candidates must meet all of the following eligibility requirements:
• Hold a doctorate in biomedical sciences, medicine, or a related field, including engineering or the physical sciences.
• As of Sept. 3, 2025, run an independent lab and hold a full-time appointment at the rank of assistant professor. (Appointments such as research assistant professor, adjunct assistant professor, assistant professor research track, visiting professor, or instructor are not eligible).
  • Current appointments such as research assistant professor, adjunct assistant professor, assistant professor research track, visiting professor, or instructor are not eligible to apply.
• Must not have been appointed as an assistant professor and run an independent lab at any institution prior to June 11, 2021, whether or not such an appointment was on a tenure track. Time spent in clinical internships, residencies, in work toward board certification, or on parental leave does not count as part of this four-year limit. Candidates who need an exception on the four-year limit should contact Pew’s program office to ensure that application reviewers are aware an exception has been given.
  • Please note that the eligibility criteria above have been temporarily expanded to account for COVID-related lab shutdowns. This extension will end after this upcoming application cycle. Beginning next year, the eligibility window for the 2027 grant will revert to the three-year period. Please direct any questions to the program office at scholarsapp@pewtrusts.org.
• May apply to the program a maximum of two times. All applicants must be nominated by their institution and must complete the 2026 online application.
• If applicants have appointments at more than one eligible nominating institution or affiliate, they may not reapply in a subsequent year from a different nominating entity.
• May not be nominated for the Pew Scholars Program and the Pew-Stewart Scholars Program for Cancer Research in the same year.

Based on their performance during their education and training, candidates should demonstrate outstanding promise as contributors in science relevant to human health. This program does not fund clinical trials research. Strong proposals will incorporate particularly creative and pioneering approaches to basic, translational, and applied biomedical research. Candidates whose work is based on biomedical principles but who bring in concepts and theories from more diverse fields are encouraged to apply.

Ideas with the potential to produce an unusually high impact are encouraged. Selection of the successful candidates will be based on a detailed description of the work that the applicant proposes to undertake, evaluations of the candidate’s performance, and notable past accomplishments, including honors, awards, and publications. In evaluating the candidates, the National Advisory Committee gives considerable weight to both the project proposal and the researcher, including evidence that the candidate is a successful independent investigator and has the skill set needed to carry out their high-impact proposal.

Funding from the NIH, other government sources, and project grants from nonprofit associations do not pose a conflict with the Pew scholars program. If you have questions concerning eligibility, please contact Pew Biomedical Programs (scholarsapp@pewtrusts.org) in advance of applying.

Funding Terms

An award of $75,000 per year for four years will be provided to the sponsoring institution for use by the scholar, subject to annual review of the scholar’s progress. Grant agreements will be issued in August of the award year. The awarded funds may be used at the discretion of the Pew scholar, for personnel, equipment, supplies, or travel directly related to the scholar's research and as to best advance his or her research and career.

• The amount of the award that may be used for the principal investigator’s salary is limited to $12,500 per year (including benefits) or $50,000 over the duration of the grant. There are no limits on student or postdoctoral salaries.
• Not more than 8 percent ($24,000) of the total award value may be allocated for facilities and administration (F&A) charges or indirect costs (IDCs).
• Should the funds not be immediately required, they may be accumulated and carried over through the grant period and, with written approval of the program office, the grant may receive a no-cost extension for one additional year (without additional funds).
• Subawards are allowed.

Limit: 8* // Tickets Available: 0

* U of A may submit eight (8) concept papers: four (4) in medical sciences and four (4) in science & engineering.

Medical Sciences: Limit: 4 // Available: 0
J. Rutherford (Nursing and Health Sciences)
S. Hamilton (Cellular and Molecular Medicine) 
R. Goyal (Obstetrics and Gynecology) 
M. Liang (Physiology) 

Science and Engineering -  Limit: 4 // Available: 0
R. Schomer (Plant Sciences)
E. Azimi (Electrical and Computer Engineering)
C. Cartmell (Pharmacology)
J. Green (Environmental Science) 

Program Description

Full sponsor guidelines https://www.wmkeck.org/research-overview/

Post selection as one of the pre-proposals, a concept review Zoom will be held with the W.M. Keck Foundation, RDS, and the UA Foundation in January will determine which one medical research and one science and engineering concept paper will be moved to a Phase 1 Submission.

The W.M. Keck Foundation Research Program uses a three-step process for this opportunity. The first step is a Concept paper. The next steps are by the foundation’s invitation. U of A review criteria reflect previous interactions with the W.M. Keck Foundation. Proposals should focus on basic, fundamental science with broad applications. Grants range from $1 million to $5 million and are typically $2 million or less, and more specifically in the $1.2 to $1.3 million range.

The proposed work should show a significant leap forward rather than an extension of existing work.

To be considered by Keck, applicants must have a statement expressing that the project is not a good fit due to risk (rather than technical or theoretical fit) or a decline from a federal program where the summary statement or individual reviews highlight the incredible novelty, but the high-risk nature that makes it difficult to fund at the federal level.

The Science and Engineering Research Program seeks to benefit humanity by supporting high-risk/high-impact projects that are distinctive and novel in their approach to intractable problems, push the edge of their field, or question the prevailing paradigm. Past grants have been awarded to support pioneering science and engineering research and the development of promising new technologies, instrumentation, or methodologies.

The Medical Research Program seeks to advance the frontiers of medicine to benefit humanity by supporting high-risk/high-impact projects that are distinctive and novel in their approach to intractable problems, push the edge of their field, or question the prevailing paradigm. Past grants have supported pioneering biological research, basic research, and the development of promising new technologies. The Keck Foundation does NOT fund work that is clinical, applied, or translational; treatment trials; or research for the sole purpose of drug development.

Both senior and early career investigators are encouraged to apply. Team approaches, including interdisciplinary teams, are encouraged.